AHRQ: Supplemental Evidence and Data Request on Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features Federal Register

Mar 29, 2022 - The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions to inform its review on Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features, including those that describe adverse events. Includes background information and key questions related to the review, as well as a list of potential effect modifiers and subgroups of interest. Submissions are due by April 28, 2022.

view details